A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)

INTRODUCTION: Osimertinib may be effective in treating central nervous system (CNS) metastasis, but its efficacy in treating radiation therapy (RT)-naive metastasis is unclear. The OCEAN study assessed the efficacy of osimertinib against RT-naive CNS metastasis in patients previously treated (T790M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakuda, Kazushige, Yamaguchi, Hiroyuki, Kenmotsu, Hirotsugu, Fukuda, Minoru, Ito, Kentaro, Tsuchiya-Kawano, Yuko, Tanaka, Kentaro, Harada, Taishi, Nakatani, Yuki, Miura, Satoru, Yokoyama, Toshihide, Nakamura, Tomomi, Izumi, Miiru, Nakamura, Atsushi, Ikeda, Satoshi, Takayama, Koichi, Yoshimura, Kenichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Sugio, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689268/
https://www.ncbi.nlm.nih.gov/pubmed/38046380
http://dx.doi.org/10.1016/j.jtocrr.2023.100587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689268/
https://www.ncbi.nlm.nih.gov/pubmed/38046380
http://dx.doi.org/10.1016/j.jtocrr.2023.100587

Ejemplares similares